title: [Treatment of recurrent congenital ocular toxoplasmosis. Our initial experience with Fansidar].
abstract: Congenital ocular toxoplasmosis with recurrences must be treated by Spiramycin destroys trophozoites when they escape from the true cysts. Fansidar (Pyrimethamine + Sulfadoxine) seems to have less efficacity than Pyrimethamine with Sulfadiazine.
authors.forename: P
authors.initials: P
authors.lastname: Comte
authors.forename: P
authors.initials: P
authors.lastname: Verin
authors.forename: M
authors.initials: M
authors.lastname: Le Bras
mesh_terms: D000293:Adolescent; D000328:Adult; D000962:Antimalarials / Q000627:therapeutic use*; D002648:Child; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D011739:Pyrimethamine / Q000627:therapeutic use*; D012008:Recurrence; D013413:Sulfadoxine / Q000627:therapeutic use*; D013424:Sulfanilamides / Q000627:therapeutic use*; D013997:Time Factors; D014126:Toxoplasmosis, Ocular / Q000151:congenital / Q000188:drug therapy*
chemical_list: D000962:Antimalarials; D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine
vernacular_title: Traitement de la toxoplasmose oculaire congénitale à rechutes. Notre première expérience du Fansidar.